Olga Granaturova

Bio:

Olga Granaturova is a repeat biotech founder, venture investor, and experienced company builder who has co-founded and led multiple biotech companies, and held senior leadership roles across the pharmaceutical and biotech industry, including Merck, Pfizer, Bristol Myers Squibb, Evotec, Parthenon Therapeutics, Normunity, and PriveBio. She is currently Managing Partner of ANAMAX Innovation, a biotech venture studio, and Co-Founder and President of PriveBio, a biotechnology company developing first-in-class therapeutics targeting metabolic dysfunction and fibro-inflammation in cardiorenal-metabolic diseases.

Olga brings deep expertise in company formation, corporate strategy, fundraising, business development, and M&A across all stages of drug development. Named to Inc. Magazine’s Female Founders 100, she also founded Brighter Ventures, a nonprofit supporting women-led entrepreneurship and AI-driven innovation in life sciences.